More on BBIO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (9.6 Score)
- Holders

Upcoming Events

- Earnings (8/5/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BridgeBio Pharma (NQ:BBIO)
Delayed: 65.36 -0.81 (1.22%)
Prev. Close $66.17  
Open$64.41 
52 Wk High$ 
52 Wk Low$ 
Day High$66.06 
Day Low$63.63 
P/E N/A  
EPS$ 
Volume3,243,994 

Friends, Peers and Foes (?): ABBV, ASND, ARGX, ALNY, AMGN (more...)

Mar 6, 2026 04:58 PM Form 4 BridgeBio Pharma, Inc. For: Mar 04 Filed by: Ellis Andrea
Mar 4, 2026 04:18 PM Form 144 BridgeBio Pharma, Inc. Filed by: Ellis Andrea
Mar 4, 2026 07:30 AM BridgeBio to present FORTIFY trial data at MDA conference
Mar 4, 2026 07:30 AM BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference
Mar 4, 2026 07:30 AM BridgeBio to present FORTIFY trial data at MDA conference
Mar 4, 2026 07:30 AM BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference
Mar 3, 2026 04:21 PM Form 4 BridgeBio Pharma, Inc. For: Feb 27 Filed by: Valantine Hannah
Feb 27, 2026 04:31 PM Form 144 BridgeBio Pharma, Inc. Filed by: Valantine Hannah
Feb 27, 2026 04:18 PM Form 4 BridgeBio Pharma, Inc. For: Feb 26 Filed by: Apuli Maricel
Feb 25, 2026 09:43 AM BridgeBio Pharma (BBIO) PT Raised to $95 at Truist Securities
View All Articles

Entities mentioned with BBIO

View All Entities